+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Drugs Market Research Reports

From
Malignant Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Merkel Cell Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Castration Resistant Prostate cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Metastatic HER2 positive breast cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic HER2 positive breast cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Metastatic Pancreatic Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Pancreatic Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Metastatic Uveal Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Uveal Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Mouth Neoplasms - Pipeline Insight, 2024 - Product Thumbnail Image

Mouth Neoplasms - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 230 Pages
  • Global
From
FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

FGFRpositive Gastroesophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2024 - Product Thumbnail Image

Idiopathic CD4+ Lymphocytopenia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Metastatic Urothelial Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Urothelial Carcinoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 150 Pages
  • Global
From
Cancer Pain - Pipeline Insight, 2024 - Product Thumbnail Image

Cancer Pain - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
chemotherapy-induced bone marrow toxicities - Pipeline Insight, 2024 - Product Thumbnail Image

chemotherapy-induced bone marrow toxicities - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
HPV-induced Cutaneous Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

HPV-induced Cutaneous Tumors - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Oncology Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cancer. These drugs are used to treat a variety of cancers, including breast, lung, and prostate cancer. Oncology drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as radiation and chemotherapy. The Oncology Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. These companies are constantly researching and developing new drugs to treat cancer, as well as improving existing treatments. Additionally, many smaller companies are also involved in the Oncology Drugs market, providing innovative treatments and therapies. Show Less Read more